Moshe Levy
Medical Oncology · Dallas, TX
CMS Profile ID: 833077 · NPI: 1518059807
Total Disclosed General Payments
$709,682.37
General-payment records
609
CMS Program Year
2025
Most of this (about 74%) was payments for services other than consulting, including faculty or speaking services outside continuing education.
Payments by Type
| Payment Type | Amount |
|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $525,581.56 |
| Consulting Fee | $102,241.95 |
| Travel and Lodging | $71,562.20 |
| Food and Beverage | $9,426.66 |
| Honoraria | $870.00 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| Syndax Pharmaceuticals, Inc. | $110,252.09 |
| Incyte Corporation | $99,475.01 |
| E.R. Squibb & Sons, L.L.C. | $85,163.47 |
| Geron Corporation | $45,285.72 |
| BeOne Medicines USA, Inc. | $38,842.66 |
| ABBVIE INC. | $36,910.88 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2025 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by exact NPI 1518059807 on the
official CMS Open Payments portal.
Verify this record with CMS
- Confirm the provider's exact NPI: 1518059807.
- Select program year 2025 and general payments in the CMS portal.
- Check individual payment records and their nature-of-payment categories.